Old Web
English
Sign In
Acemap
>
authorDetail
>
R. G. Stoller
R. G. Stoller
Every Three Weeks
Retaspimycin hydrochloride
Medicine
Docetaxel
Pharmacokinetics
2
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and activity of IPI-504 (retaspimycin hydrochloride) and docetaxel in pretreated patients (pts) with metastatic non-small cell lung cancer (NSCLC).
2011
Journal of Clinical Oncology
G. J. Riely
Scott N. Gettinger
R. G. Stoller
N. Y. Gabrail
Grace K. Dy
Glen J. Weiss
C. Tunkey
G. Skliris
S. Strychor
Joi Dunbar
D. DeLucia
Robert W. Ross
Jhanelle E. Gray
Show All
Source
Cite
Save
Citations (8)
A phase Ib trial of IPI-504 (retaspimycin hydrochloride), a novel Hsp90 inhibitor, in combination with docetaxel
2009
Journal of Clinical Oncology
G. J. Riely
R. G. Stoller
Merrill J. Egorin
David B. Solit
Joi Dunbar
A Savage
John R. Walker
David Grayzel
Robert W. Ross
Glen J. Weiss
Show All
Source
Cite
Save
Citations (8)
1